KRAS and colorectal carcinoma: Since our data showed that loss of PTPRS increased the phosphorylation of ERK in tumor cells driven by both mutant KRAS as well as wild-type KRAS, we sought to further confirm the effects of PTPRS knockout (KO) on CRC cells, independent of KRAS mutation status.